{"id":"https://openalex.org/W2409145372","doi":null,"title":"[Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases].","display_name":"[Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases].","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2409145372","mag":"2409145372","pmid":"https://pubmed.ncbi.nlm.nih.gov/23819337"},"language":"ru","primary_location":{"id":"pmid:23819337","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23819337","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"Controlled Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/5036bbf9a7c740e2b20f00cc162ea769","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000308788","display_name":"Sergey Valentinovich Moiseev","orcid":"https://orcid.org/0000-0002-7232-4640","observed_orcids":["https://orcid.org/0000-0002-7232-4640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S V Moiseev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009125671","display_name":"Pavel I Novikov","orcid":"https://orcid.org/0000-0003-0148-5655","observed_orcids":["https://orcid.org/0000-0003-0148-5655"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P I Novikov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111821347","display_name":"\u0415 \u041d \u0421\u0435\u043c\u0435\u043d\u043a\u043e\u0432\u0430","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E N Semenkova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063114831","display_name":"Leonid Aleksandrovich Strizhakov","orcid":"https://orcid.org/0000-0002-2291-6453","observed_orcids":["https://orcid.org/0000-0002-2291-6453"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L A Strizhakov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111076797","display_name":"Sergei V. Gulyaev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S V Gulyaev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015465555","display_name":"T N Yanushkevich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T N Yanushkevich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003669962","display_name":"\u041d\u0438\u043a\u0438\u0444\u043e\u0440\u043e\u0432\u0430 \u041d\u0430\u0434\u0435\u0436\u0434\u0430 \u0412\u0438\u043a\u0442\u043e\u0440\u043e\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0001-8060-109X","observed_orcids":["https://orcid.org/0000-0001-8060-109X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N V Nikiforova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014528204","display_name":"Alexey D. Meshkov","orcid":"https://orcid.org/0000-0002-5187-0108","observed_orcids":["https://orcid.org/0000-0002-5187-0108"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A D Meshkov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004466709","display_name":"V Panasyuk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V V Panasyuk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055511939","display_name":"Yu D Sokorin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu D Sokorin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001242962","display_name":"Marina V. Taranova","orcid":"https://orcid.org/0000-0002-7363-6195","observed_orcids":["https://orcid.org/0000-0002-7363-6195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M V Taranova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031369712","display_name":"S A Parfenova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S A Parfenova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035153901","display_name":"L V Dubrovskaya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L V Dubrovskaya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050704044","display_name":"\u0415. \u0421. \u0416\u0430\u0431\u0438\u043d\u0430","orcid":"https://orcid.org/0000-0002-9001-8743","observed_orcids":["https://orcid.org/0000-0002-9001-8743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E S Zhabina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104636430","display_name":"E I Kuznetsova","orcid":"https://orcid.org/0000-0002-7857-6320","observed_orcids":["https://orcid.org/0000-0002-7857-6320"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E I Kuznetsova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016820965","display_name":"I A Lopatina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I A Lopatina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079058999","display_name":"Nikolay M. Bulanov","orcid":"https://orcid.org/0000-0002-3989-2590","observed_orcids":["https://orcid.org/0000-0002-3989-2590"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N M Bulanov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103002995","display_name":"Nikolay Alekseevich Mukhin","orcid":"https://orcid.org/0000-0003-0382-6230","observed_orcids":["https://orcid.org/0000-0003-0382-6230"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N A Mukhin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2227,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.55648581,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"85","issue":"5","first_page":"37","last_page":"43"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/severe-adverse-events","display_name":"severe adverse events","score":0.8140000104904175},{"id":"https://openalex.org/keywords/rheumatic-diseases","display_name":"rheumatic diseases","score":0.9750000238418579},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9539999961853027},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":1.0},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9049999713897705},{"id":"https://openalex.org/keywords/anca-associated-vasculitis","display_name":"ANCA-associated vasculitis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":1.0},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8420000076293945},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.9089999794960022},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9236787557601929},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8967553377151489},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8808163404464722},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7153775691986084},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6269141435623169},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.5916147232055664},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5227080583572388},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5205803513526917},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4547313153743744},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36249062418937683},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32513728737831116},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14484462141990662},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.13544777035713196},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.08216467499732971},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005818","descriptor_name":"Genetic Engineering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D012216","descriptor_name":"Rheumatic Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012216","descriptor_name":"Rheumatic Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056648","descriptor_name":"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D056648","descriptor_name":"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23819337","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23819337","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"Controlled Clinical Trial"},{"id":"pmh:oai:doaj.org/article:5036bbf9a7c740e2b20f00cc162ea769","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5036bbf9a7c740e2b20f00cc162ea769","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432, Vol 85, Iss 5, Pp 37-43 (2013)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:5036bbf9a7c740e2b20f00cc162ea769","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5036bbf9a7c740e2b20f00cc162ea769","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432, Vol 85, Iss 5, Pp 37-43 (2013)","raw_type":"article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2210494829","https://openalex.org/W1978446286","https://openalex.org/W2035642138","https://openalex.org/W2091339861","https://openalex.org/W2025385351","https://openalex.org/W2278634532","https://openalex.org/W2054241726","https://openalex.org/W7097450762","https://openalex.org/W2170350220","https://openalex.org/W2772399771"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"assess":[2],"the":[3,96,111,121,174,177,187],"risk":[4],"of":[5,67,95,113,123,147,179,189],"severe":[6,99,115,190],"adverse":[7],"events":[8],"(AEs)":[9],"within":[10],"6":[11,102],"months":[12],"after":[13,135,141],"treatment":[14,137,156],"with":[15,20,34,157,170],"biological":[16,51,180],"agents":[17,52,181],"in":[18,79,92,101,107,118,130,168,186],"patients":[19,33,68,109,169],"rheumatic":[21],"diseases":[22],"(RD).":[23],"SUBJECTS":[24],"AND":[25],"METHODS:":[26],"The":[27,65,145],"6-month":[28],"open-label":[29],"trial":[30],"included":[31],"107":[32,97],"rheumatoid":[35],"arthritis,":[36],"antineutrophil":[37],"cytoplasmic":[38],"antibody-associated":[39],"vasculitides,":[40],"systemic":[41,128],"lupus":[42],"erythematosus,":[43],"and":[44,59,76,82,125,127,138,153,160],"other":[45,161],"RDs":[46],"who":[47],"received":[48],"genetically":[49],"engineered":[50],"(GEBAs),":[53],"primarily":[54],"rituximab":[55,136],"(n":[56,61],"=":[57,62],"66)":[58],"infliximab":[60,124,142],"31).":[63],"RESULTS:":[64],"majority":[66],"were":[69,87],"noted":[70],"to":[71,164,194],"have":[72],"improvements,":[73],"including":[74],"complete":[75],"partial":[77],"remission":[78],"62":[80],"(57.9%)":[81],"42":[83],"(39.3%),":[84],"respectively.":[85],"There":[86],"mild":[88],"or":[89],"moderate":[90],"AEs":[91,100,152],"22":[93],"(20.6%)":[94],"patients,":[98],"(5.6%):":[103],"grade":[104],"IV":[105],"neutropenia":[106],"2":[108,119,131],"(after":[110,120],"use":[112,178],"rituximab),":[114,126],"infusion":[116,151],"reactions":[117],"administration":[122],"infections":[129,154],"(fatal":[132],"nocardial":[133],"sepsis":[134,140],"unspecified":[139],"treatment).":[143],"CONCLUSION:":[144],"rate":[146],"serious":[148],"AEs,":[149],"mainly":[150],"during":[155],"infliximab,":[158],"rituximab,":[159],"GEBAs":[162],"proved":[163],"be":[165],"relatively":[166],"low":[167],"different":[171],"RDs.":[172],"At":[173],"same":[175],"time,":[176],"could":[182],"lower":[183],"RD":[184],"activity":[185],"presence":[188],"visceral":[191],"injuries":[192],"refractory":[193],"conventional":[195],"immunosuppressive":[196],"therapy.":[197]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}